Slovakia is facing a coronavirus-induced COVID-19 disease. It is a new strain of virus that has not yet been known in humans. The disease is a droplet infection. The aim of the project is to create your own diagnostic set to detect the presence of coronavirus (qPCR diagnostic set) from Slovak sources and components that can be produced in Slovakia. At the same time, the aim is to ensure and support both Slovak health professionals, strength components and industry, while maintaining Slovakia’s self-sufficiency in the possession of a sufficient number of tests, which will be used according to the needs. The project will also strengthen the allocation of test sites in Slovakia and at the same time it will be possible to store biological material for further testing in the future. The project will thus allow for increased testing capacity for further waves of the SARS-Cov-2 epidemic. At the same time, by archiving samples, it will contribute to a global initiative aimed at more detailed identification of the virus, its mutations and the development of new, faster and more effective methods of diagnosis and therapy. The Ministry of Health of the Slovak Republic is involved in the implementation of the project as an applicant who will be responsible for the purchase of the components necessary for the creation of the diagnostic set and will be responsible for project management. As a partner, the Comenius University in Bratislava will participate in the implementation of the project through its organizational components:- Science Park of Comenius University – Jesseni Medical Faculty of Comenius University in MartineThe main task of partners is to participate in the collection of samples of Covid 19, their testing in laboratory conditions and their maintenance for further research in the field of diagnostics and treatment of Covid 19.Projekt covers the whole territory of the Slovak Republic and will be implemented for 12 months through three aktivít:Rozšírenie of the testing network of organisations on the optimisation of emergency systems in the framework of the university – the Faculty of Medicine of the University of Martin. Jesseni’s Faculty of Medicine in Martin has adequate spatial and instrumentation equipment for SARS-Cov-2 testing. In preparation for testing, it provided sufficient staffing capacity covering the entire process – i.e. from the collection of biological material to its complex processing. At the same time, it tested reference samples of the virus, thereby building on its procedures. After the approval of the project, Jesseni’s Faculty of Medicine in Martin can be included in the system of testing centres, which will help expand their network and at the same time streamline the way and system of testing in the region and trans-regionally. As part of the testing, Jesseni’s Faculty of Medicine in Martin will use qPCR tests developed within the Comenius University’s Scientific Park, so that almost the entire testing process can cover the in-house. The current situation related to the spread of COVID-19 infection requires the rapid identification of individuals infected with the virus, particularly during the latent period, or those who are experiencing infection without clinical signs. This requires massive population testing with a massive parallel screening set by Jesseni’s Faculty of Medicine in Martin after collecting sufficient samples (Biobanking) and validating the newly proposed screening test methodology. In addition to significant scientific potential, this proposed method also has economic benefits. At the same time, it will increase the number of persons examined, up to several tens of thousands/24 hours. Securing stockpiles of qPCR COVID-19 diagnostic set – contribution to the objective of providing special equipment essential for a timely and efficient COVID-19 Biobanking intervention – contribution to the objective of supporting education and information and experience exchange measures. COVID-19 caused by SARS-CoV-2 is a major challenge not only for our health and economic system. This is a global problem, in which almost all countries with available scientific and professional capacities participate in the solution. Healthcare professionals and volunteers do a great job in direct diagnosis and therapy or care for patients with COVID 19, but we can effectively defeat the virus only on the basis of its detailed knowledge. The collection of biological material and its storage in a biobank will significantly support the work of researchers involved in the development of new, more efficient diagnostic kits, as well as scientists working together to develop vaccines or therapists to combat the disease. The collection of samples (sters) in patients with a positive test for SARS-Cov-2 takes place in every developed country of the world and Slovakia has the ambition to participate in strategies in diagnosis and treatment that can be implemented in our environment.